Basic Information
| LncRNA/CircRNA Name | LINC01508 |
| Synonyms | NA |
| Region | GRCh38_9:90300902-90433505 |
| Ensemble | ENSG00000231107 |
| Refseq | NR_109795 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | breast cancer |
| ICD-0-3 | C50 |
| Methods | qPCR |
| Sample | breast cancer tissues |
| Expression Pattern | up-regulated |
| Function Description | The expression of two up-regulated lncRNAs (LINC01508 and DSCAM-AS1) and two down-regulated lncRNAs (lnc-MGST1-2 and lnc-BTG2-2) was consistent with the microarray analysis and showed a significant difference between RCT and RT. The expression level of LINC01508 was significantly related to poor prognosis. |
| Pubmed ID | 31938376 |
| Year | 2018 |
| Title | Identification of lncRNAs via Microarray Analysis for Predicting HER2-negative Breast Cancer Response to Neoadjuvant Chemotherapy |
External Links
| Links for LINC01508 | GenBank HGNC NONCODE |
| Links for breast cancer | OMIM COSMIC |